miR-125b predicts childhood acute lymphoblastic leukaemia poor response to BFM chemotherapy treatment von Piatopoulou, Despina, Avgeris, Margaritis, Marmarinos, Antonios, Xagorari, Marieta, Baka, Margarita, Doganis, Dimitrios, Kossiva, Lydia, Scorilas, Andreas, Gourgiotis, Dimitrios

Volltext

Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia von Piatopoulou, Despina, Avgeris, Margaritis, Drakaki, Ioanna, Marmarinos, Antonios, Xagorari, Marieta, Baka, Margarita, Pourtsidis, Apostolos, Kossiva, Lydia, Gourgiotis, Dimitrios, Scorilas, Andreas

Volltext

Overexpression of BCL2 and BAX following BFM induction therapy predicts ch-ALL patients’ poor response to treatment and short-term relapse von Stamati, Lamprini, Avgeris, Margaritis, Kosmidis, Helen, Baka, Margarita, Anastasiou, Theodora, Piatopoulou, Despina, Scorilas, Andreas, Gourgiotis, Dimitrios

Volltext

BCL2L12 improves risk stratification and prediction of BFM-chemotherapy response in childhood acute lymphoblastic leukemia von Avgeris, Margaritis, Stamati, Lamprini, Kontos, Christos K., Piatopoulou, Despina, Marmarinos, Antonios, Xagorari, Marieta, Baka, Margarita, Doganis, Dimitrios, Anastasiou, Theodora, Kosmidis, Helen, Gourgiotis, Dimitrios, Scorilas, Andreas

Volltext

Cord blood nesfatin-1 in large for gestational age pregnancies von Boutsikou, Theodora, Briana, Despina D., Boutsikou, Maria, Kafalidis, George, Piatopoulou, Despoina, Baka, Stavroula, Hassiakos, Demetrios, Gourgiotis, Demetrios, Malamitsi-Puchner, Ariadne

Volltext